Enzymes noncompetitive inhibitors

Table 3.4 Some examples of noncompetitive enzyme inhibitors in clinical use or trials...

Dimethirimol and ethirimol are effective fungicides at concentrations in the plant of approximately 10M. At the sublethal level concentration in the fungi is probably half that in the plant. Hence, it is assumed that these active substances act as noncompetitive enzyme inhibitors (Bent, 1970 Sampson, 1969 Calderbank,... 

Indicate whether each of the following describes a competitive or a noncompetitive enzyme inhibitor ... 

If the inhibitor combines irreversibly with the enzyme—for example, by covalent attachment—the kinetic pattern seen is like that of noncompetitive inhibition, because the net effect is a loss of active enzyme. Usually, this type of inhibition can be distinguished from the noncompetitive, reversible inhibition case since the reaction of I with E (and/or ES) is not instantaneous. Instead, there is a time-dependent decrease in enzymatic activity as E + I El proceeds, and the rate of this inactivation can be followed. Also, unlike reversible inhibitions, dilution or dialysis of the enzyme inhibitor solution does not dissociate the El complex and restore enzyme activity. 

In noncompetitive inhibition, binding of the inhibitor does not affect binding of substrate. Formation of both EI and EIS complexes is therefore possible. However, while the enzyme-inhibitor complex can still bind substrate, its efficiency at transforming substrate to product, reflected by is decreased. Noncompetitive... 

In this chapter we described the thermodynamics of enzyme-inhibitor interactions and defined three potential modes of reversible binding of inhibitors to enzyme molecules. Competitive inhibitors bind to the free enzyme form in direct competition with substrate molecules. Noncompetitive inhibitors bind to both the free enzyme and to the ES complex or subsequent enzyme forms that are populated during catalysis. Uncompetitive inhibitors bind exclusively to the ES complex or to subsequent enzyme forms. We saw that one can distinguish among these inhibition modes by their effects on the apparent values of the steady state kinetic parameters Umax, Km, and VmdX/KM. We further saw that for bisubstrate reactions, the inhibition modality depends on the reaction mechanism used by the enzyme. Finally, we described how one may use the dissociation constant for inhibition (Kh o.K or both) to best evaluate the relative affinity of different inhibitors for ones target enzyme, and thus drive compound optimization through medicinal chemistry efforts. 

Figure 5.4 Effects of [S] KAl ratio on the apparent IC value for competitive (closed circles), noncompetitive (closed squares a = 1) and uncompetitive (open circles) enzyme inhibitors. Note that the x-axis is plotted on a logarithmic scale for clarity.

Enzymatic reactions can be impeded by the addition of exogenous molecules. This is how drugs are used to control biochemical reactions, and most drugs are used for inhibitory functions. Drugs may function as competitive inhibitors or as noncompetitive inhibitors. Competitive inhibitors compete with the substrates for binding to the active sites, whereas noncompetitive inhibitors bind to another location (allosteric site) but affect the active site and its consequential interactions with the substrates. Some drugs used as enzyme inhibitors are the following ... 

Mycophenolate sodium (62 Myfortic Norvatis, 2003) is an immunosuppressant drug used to prevent rejection in organ transplantation. It is a selective, noncompetitive, reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH), the rate-limiting enzyme in the de novo pathway of guanosine nucleotide synthesis. Thus, mycophenolic acid (61), originally... 

Most enzyme inhibitors act reversibly—i. e., they do not cause any permanent changes in the enzyme. However, there are also irreversible inhibitors that permanently modify the target enzyme. The mechanism of action of an inhibitor—its inhibition type—can be determined by comparing the kinetics (see p.92) of the inhibited and uninhibited reactions (B). This makes it possible to distinguish competitive inhibitors (left) from noncompetitive inhibitors (right), for example. Allosteric inhibition is particularly important for metabolic regulation (see below). 

Enzyme inhibition by an extremely tight-binding inhibi-tor When the substrate(s), regardless of the detailed mode of inhibition, has (have) a negligible effect on the formation of enzyme-inhibitor (E-I) complex, the net result is depletion i.e., the removal of enzyme by the inhibitor from the reaction). The observed kinetic pattern is identical to the simple noncompetitive inhibition case the substrate and the inhibitor do not affect each other s binding, because only V sk is changed due to reduced enzyme concentration, while remains unaltered. 

C. Noncompetitive inhibitors bind to a site on the enzyme other than the substrate binding site to form an inactive enzyme-inhibitor complex. 

Any substance that can diminish the velocity of an enzyme-catalyzed reaction is called an inhibitor. Reversible inhibitors bind to enzymes through noncovalent bonds. Dilution of the enzyme-inhibitor complex results in dissociation of the reversibly bound inhibitor, and recovery of enzyme activity. Irreversible inhibition occurs when an inhibited enzyme does not regain activity on dilution of the enzyme-inhibitor complex. The two most commonly encountered types of inhibition are competitive and noncompetitive. 

Fiqtire 3.5 (a) Competitive inhibition inhibitor and substrate compete for the same binding site. For example, indole, phenol, and benzene bind in the binding pocket of chymotrypsin and inhibit the hydrolysis of derivatives of tryptophan, tyrosine, and / phenylalanine, (b) Noncompetitive inhibition inhibitor and substrate bind simultaneously to the enzyme. An example is the inhibition of fructose 1,6-diphosphatase by AMP. This type of inhibition is very common with multisubstrate enzymes. A rare example of / uncompetitive inhibition of a single-substrate enzyme is the inhibition of alkaline phosphatase by L-phenylalanine. This enzyme is composed of two identical subunitjs, so presumably the phenylalanine binds at one site and the substrate at the other. [From N. K. Ghosh and W. H. Fishman, J. Biol. Chem. 241, 2516 (1966) see also M. Caswell and M. Caplow, Biochemistry 19, 2907 (1980). 

Several variations of the mechanism for noncompetitive inhibition are possible. One case is when the enzyme-inhibitor-substrate complex can be decomposed to produce a product and the enzyme-inhibitor complex. This mechanism can be described by adding the following slow reaction to Eq. (2.49)... 

Noncompetitive inhibitors can bind to both the enzyme and enzyme-substrate complex to form either an enzyme-inhibitor complex or an enzyme-inhibitor-substrate complex. The net result is a decrease in Vmax but no change in Km. Metyrapone (Figure 9.6), a well-known inhibitor of monooxygenase reactions, can also, under some circumstances, stimulate metabolism in vitro. In either case the effect is noncompetitive, in that the Km does not change, whereas Vm. does, decreasing in the case of inhibition and increasing in the case of stimulation. 

FIGURE 4.14 Effect of a pure noncompetitive, reversible inhibitor on enzyme kinetics... 

Enzyme inhibition Many types of molecule exist which are capable of interfering with the activity of an individual enzyme. Any molecule which acts directly on an enzyme to lower its catalytic rate is called an inhibitor. Some enzyme inhibitors are normal body metabolites that inhibit a particular enzyme as part of the normal metabolic control of a pathway. Other inhibitors may be foreign substances, such as drugs or toxins, where the effect of enzyme inhibition could be either therapeutic or, at the other extreme, lethal. Enzyme inhibition may be of two main types irreversible or reversible, with reversible inhibition itself being subdivided into competitive and noncompetitive inhibition. Reversible inhibition can be overcome by removing the inhibitor from the enzyme, for example by dialysis (see Topic B6), but this is not possible for irreversible inhibition, by definition. 

Answer The graph gives us several pieces of information. First, the inhibitor prevents the enzyme from achieving the same Fmax as in the absence of inhibitor. Second, the overall shape of the two curves is very similar at any [S] the ratio of the two velocities ( inhibitor) is the same. Third, the velocity does not change very much above [S] = 1 mM, so at much higher [S] the observed velocity is essentially Vmax for each curve. Fourth, if we estimate the [S] at which -2-Fmax is achieved, this value is nearly identical for both curves. Noncompetitive inhibition, a special form of mixed inhibition that is rarely observed, alters the Fmax of enzymes but leaves Km unchanged. Thus, acetazolamide acts as a noncompetitive (mixed) inhibitor of carbonic anhydrase. 

Substances which interfere with the specific binding of the substrate to the prosthetic group are specific inhibitors, and differ significantly from agents, which cause nonspecific denaturation of an enzyme (or any protein). Two basic types of inhibitions are recognized competitive inhibition and noncompetitive inhibition. Competitive inhibition is the result of a reversible formation of an enzyme inhibitor complex (El) ... 

---